Anna Yang, | |
350 Houbolt Rd Ste 104, Joliet, IL 60431-8305 | |
(815) 553-0990 | |
(815) 553-0991 |
Full Name | Anna Yang |
---|---|
Gender | Female |
Speciality | Podiatry |
Experience | 9 Years |
Location | 350 Houbolt Rd Ste 104, Joliet, Illinois |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1659754000 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213ES0103X | Podiatrist - Foot & Ankle Surgery | 135000895 (Illinois) | Primary |
Provider Name | Breck Tiernan Pc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1730354382 PECOS PAC ID: 6901961465 Enrollment ID: O20090217000181 |
News Archive
The Hill reports that delaying a scheduled pay cut for one year to doctors who treat Medicare patients would cost $25 billion.
According to press reports, U.S. District Judge Freda Wolfson ruled that Nicholas Purpura and Donald R. Laster Jr., who filed their lawsuit without a lawyer, lack legal standing to challenge the 2010 Patient Protection and Affordable Care Act.
Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent. In a report in the January 17 issue of The Lancet, an international research team reports that a protocol adding lapatinib (Tykerb) to trastuzumab (Herceptin) was more effective than single-drug treatment with either drug in eliminating microscopic signs of cancer at the time the tumors were surgically removed.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced it has entered into an alliance with Eli Lilly and Company ("Lilly") to discover and develop novel therapeutic antibody products against targets submitted by Lilly.
› Verified 1 days ago
Provider Name | Foundation Foot And Ankle Center Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1962092437 PECOS PAC ID: 1456751379 Enrollment ID: O20210615002053 |
News Archive
The Hill reports that delaying a scheduled pay cut for one year to doctors who treat Medicare patients would cost $25 billion.
According to press reports, U.S. District Judge Freda Wolfson ruled that Nicholas Purpura and Donald R. Laster Jr., who filed their lawsuit without a lawyer, lack legal standing to challenge the 2010 Patient Protection and Affordable Care Act.
Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent. In a report in the January 17 issue of The Lancet, an international research team reports that a protocol adding lapatinib (Tykerb) to trastuzumab (Herceptin) was more effective than single-drug treatment with either drug in eliminating microscopic signs of cancer at the time the tumors were surgically removed.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced it has entered into an alliance with Eli Lilly and Company ("Lilly") to discover and develop novel therapeutic antibody products against targets submitted by Lilly.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Anna Yang, 350 Houbolt Rd Ste 104, Joliet, IL 60431-8305 Ph: (815) 553-0990 | Anna Yang, 350 Houbolt Rd Ste 104, Joliet, IL 60431-8305 Ph: (815) 553-0990 |
News Archive
The Hill reports that delaying a scheduled pay cut for one year to doctors who treat Medicare patients would cost $25 billion.
According to press reports, U.S. District Judge Freda Wolfson ruled that Nicholas Purpura and Donald R. Laster Jr., who filed their lawsuit without a lawyer, lack legal standing to challenge the 2010 Patient Protection and Affordable Care Act.
Using two drugs that inhibit the growth factor HER2 for preoperative treatment of early-stage HER2-positive breast cancer appears to have better results than treatment with a single agent. In a report in the January 17 issue of The Lancet, an international research team reports that a protocol adding lapatinib (Tykerb) to trastuzumab (Herceptin) was more effective than single-drug treatment with either drug in eliminating microscopic signs of cancer at the time the tumors were surgically removed.
arGEN-X BV, a biopharmaceutical company focused on the discovery and development of human antibodies using its proprietary SIMPLE Antibody platform, today announced it has entered into an alliance with Eli Lilly and Company ("Lilly") to discover and develop novel therapeutic antibody products against targets submitted by Lilly.
› Verified 1 days ago
Dr. Andrew Vernon Wahl, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1960 Essington Rd, Suite 103, Joliet, IL 60435 Phone: 815-436-3555 | |
Southshore Foot And Ankle Surgery Podiatrist Medicare: Medicare Enrolled Practice Location: 1026 Essington Rd, Joliet, IL 60435 Phone: 714-244-0101 | |
Dr. Ada Vera Paolucci, D.P.M Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1960 Essington Rd, Suite 103, Joliet, IL 60435 Phone: 815-436-3555 Fax: 815-436-3578 | |
Dr. Joe Mathew George, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1445 Essington Rd., Joliet, IL 60435 Phone: 815-741-6900 Fax: 815-741-6907 | |
Jaclyn M Schumann, Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2100 Glenwood Ave, Joliet, IL 60435 Phone: 815-725-2121 Fax: 815-741-5518 | |
Dr. An D Le, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1026 Essington Rd, Joliet, IL 60435 Phone: 714-244-0101 | |
Andrew Wahl And Ada Paolucci Podiatrist Medicare: Medicare Enrolled Practice Location: 1960 Essington Rd, Ste 103, Joliet, IL 60435 Phone: 815-436-3555 Fax: 815-436-3578 |